Contact Us
Diagnostic Radioisotopes Global Market Report 2025
Global Diagnostic Radioisotopes Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Diagnostic Radioisotopes Global Market Report 2025

By Radioisotope (Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FluoroDeoxyGlucose (FDG), Rubidium-82, Other Radioisotopes), By Imaging Modality (Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Beta Emitters), By Application (Oncology, Cardiology, Other Applications), By End User (Hospitals, Specialty Clinics, Diagnostic Centers, Academic And Research Institutes, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Diagnostic Radioisotopes Market Overview

• Diagnostic Radioisotopes market size has reached to $5.54 billion in 2024

• Expected to grow to $8.62 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%

• Growth Driver: Rising Burden Of Cancer Is Driving The Growth Of The Diagnostic Radioisotopes

• Market Trend: Technological Innovation To Drive The Nuclear Medicine Radioisotopes

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Diagnostic Radioisotopes Market?

Diagnostic radioisotopes refer to radioactive isotopes used in the field of nuclear medicine to diagnose and monitor various medical conditions. They utilize their radioactive decay properties to emit radiation, which is detected by specialized imaging equipment, allowing healthcare professionals to obtain detailed images of internal body structures and assess their function.

The main radioisotopes of diagnostic radioisotopes are technetium-99m, thallium-201, gallium-67, iodine-123, fluorodeoxyglucose (FDG), rubidium-82, and others. Technetium-99m radioisotopes are utilized extensively in medical imaging procedures due to their favorable nuclear properties and widespread availability. The imaging modalities encompass single photon emission computed tomography (SPECT), Positron Emission Tomography (PET), and beta emitters, utilized for various applications including oncology, cardiology, and others.

Diagnostic Radioisotopes Market Size and growth rate 2025 to 2029: Graph

What Is The Diagnostic Radioisotopes Market Size 2025 And Growth Rate?

The diagnostic radioisotopes market size has grown rapidly in recent years. It will grow from $5.54 billion in 2024 to $6.08 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to the discovery of radioactivity, the introduction of technetium-99m, clinical applications and research, cold war era and nuclear research, and emergence of positron emission tomography.

What Is The Diagnostic Radioisotopes Market Growth Forecast?

The diagnostic radioisotopes market size is expected to see strong growth in the next few years. It will grow to $8.62 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to emerging radioisotope production methods, expanded clinical applications, patient-centered care and safety, point-of-care imaging and environmental sustainability and green chemistry. Major trends in the forecast period include hybrid imaging techniques, theranostics, molecular imaging techniques, the use of cyclotrons or generators, and safety and radiation protection.

The forecast of 9.1% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. nuclear medicine by raising costs for technetium-99m and other critical radioisotopes imported from Canada and Belgium, potentially compromising imaging accuracy and increasing oncology and cardiology scan costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Diagnostic Radioisotopes Market Segmented?

1) By Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FluoroDeoxyGlucose (FDG), Rubidium-82, Other Radioisotopes

2) By Imaging Modality: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Beta Emitters

3) By Application: Oncology, Cardiology, Other Applications

4) By End User: Hospitals, Specialty Clinics, Diagnostic Centers, Academic And Research Institutes, Other End Users

Subsegments:

1) By Technetium-99m: Diagnostic Imaging, Cardiac Imaging, Oncology Imaging, Bone Scans, Renal Scans

2) By Thallium-201: Cardiac Imaging, Myocardial Perfusion Imaging, Stress Tests

3) By Gallium-67: Oncology Imaging (Lymphoma, Tumors), Inflammatory Disease Imaging, Infection Imaging

4) By Iodine-123: Thyroid Imaging, Neurological Imaging (Parkinson's Disease), Cardiac Imaging

5) By FluoroDeoxyGlucose (FDG): Positron Emission Tomography (PET) Imaging, Cancer Diagnosis And Staging, Neurological Imaging, Cardiac Imaging

6) By Rubidium-82: Cardiac PET Imaging, Myocardial Perfusion Imaging, Coronary Artery Disease Diagnosis

7) By Other Radioisotopes: Strontium-89 (Bone Pain Palliation), Iodine-131 (Thyroid Cancer Treatment), Samarium-153 (Bone Pain Palliation), Yttrium-90 (Cancer Treatment)

What Is Driving The Diagnostic Radioisotopes Market? Rising Burden Of Cancer Is Driving The Growth Of The Diagnostic Radioisotopes

The rising burden of cancer is expected to propel the growth of the diagnostic radioisotopes market going forward. Cancer refers to a disease in which abnormal cells divide uncontrollably and destroy body tissue. The rising burden of cancer is due to lifestyle choices, such as smoking, obesity, lack of physical activity, exposure to carcinogens, genetic predisposition, and environmental factors. Radioisotopes are powerful tools in cancer management, enabling precise diagnosis, targeted treatment, and effective monitoring of cancer progression or response to therapy. For instance, in October 2023, according to a report by the European Commission, a Europe-based governing body, new cancer cases increased by 2.3 % from 2020, reaching 2.74 million in 2022. Similarly, cancer deaths saw a 2.4 % increase compared to 2020. Therefore, the rising burden of cancer is driving the growth of the diagnostic radioisotopes industry.

Who Are The Major Players In The Global Diagnostic Radioisotopes Market?

Major companies operating in the diagnostic radioisotopes market are Cardinal Health Inc., Sumitomo Heavy Industries Ltd., BWX Technologies Inc., Lantheus Holdings, Curium Pharma, Clarity Pharmaceuticals, Bracco Diagnostic Inc., Ion Beam Applications S.A., Nordion Inc., Eckert & Ziegler AG, NorthStar Medical Radioisotopes LLC, NTP Radioisotopes SOC Ltd, Global Medical Solutions Ltd., Isotopia Molecular Imaging Ltd., Cyclopharm Limited, Trasis NV, Orano Med LLC, ARTMS Inc., Radiomedix Inc., Coqu RadioPharmaceuticals Corp., IsoTherapeutics Group LLC

What Are The Key Trends Of The Global Diagnostic Radioisotopes Market? Technological Innovation To Drive The Nuclear Medicine Radioisotopes

Major companies operating in the diagnostic radioisotopes market are focused on developing advanced radiopharmaceutical technology to enhance diagnostic accuracy, improve patient outcomes, and broaden the applications of nuclear medicine in healthcare. Advanced radiopharmaceutical technology refers to the development of innovative compounds and techniques for precise imaging and targeted therapy in nuclear medicine. For instance, in March 2022, Bracco Group, an Italy-based diagnostic imaging company, launched Blue Earth Therapeutics, a subsidiary to advance the development of next-generation therapeutic radiopharmaceutical technology. This subsidiary is focused on developing precision-targeted therapeutic radiopharmaceuticals, initially targeting prostate cancer, with plans to expand into additional disease areas in oncology.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Diagnostic Radioisotopes Market? Telix Pharmaceuticals Limited Acquired ARTMS To Enhance Isotope Production And Market Position

In April 2024, Telix Pharmaceuticals Limited, an Australia-based biotechnology company, acquired ARTMS for an undisclosed amount. Through acquisition of ARTMS, Telix Pharmaceuticals aims to bolster its supply chain and manufacturing, leveraging its cyclotron-based isotope production expertise to enhance market position and meet rising demand for diagnostic and therapeutic isotopes. ARTMS is a Canada-based provider of radioisotope technology and specializes in diagnostic radioisotopes.

What Is The Regional Outlook For The Global Diagnostic Radioisotopes Market?

North America was the largest region in the diagnostic radioisotopes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Diagnostic Radioisotopes Market?

The diagnostic radioisotopes market consists of revenues earned by entities by providing services such as radiopharmacy services, imaging services, radioisotope production and supply, diagnostic procedures, and theranostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The diagnostic radioisotopes market also includes sales of products including Indium-111, Xenon-133, Molybdenum-99, and Phosphorus-32. Values in this market are'factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Diagnostic Radioisotopes Industry?

The diagnostic radioisotopes market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic radioisotopes industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Diagnostic Radioisotopes Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $6.08 billion
Revenue Forecast In 2034 $8.62 billion
Growth Rate CAGR of 9.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FluoroDeoxyGlucose (FDG), Rubidium-82, Other Radioisotopes
2) By Imaging Modality: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Beta Emitters
3) By Application: Oncology, Cardiology, Other Applications
4) By End User: Hospitals, Specialty Clinics, Diagnostic Centers, Academic And Research Institutes, Other End Users Subsegments: 1) By Technetium-99m: Diagnostic Imaging, Cardiac Imaging, Oncology Imaging, Bone Scans, Renal Scans
2) By Thallium-201: Cardiac Imaging, Myocardial Perfusion Imaging, Stress Tests
3) By Gallium-67: Oncology Imaging (Lymphoma, Tumors), Inflammatory Disease Imaging, Infection Imaging
4) By Iodine-123: Thyroid Imaging, Neurological Imaging (Parkinson's Disease), Cardiac Imaging
5) By FluoroDeoxyGlucose (FDG): Positron Emission Tomography (PET) Imaging, Cancer Diagnosis And Staging, Neurological Imaging, Cardiac Imaging 6) By Rubidium-82: Cardiac PET Imaging, Myocardial Perfusion Imaging, Coronary Artery Disease Diagnosis 7) By Other Radioisotopes: Strontium-89 (Bone Pain Palliation), Iodine-131 (Thyroid Cancer Treatment), Samarium-153 (Bone Pain Palliation), Yttrium-90 (Cancer Treatment)
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Cardinal Health Inc., Sumitomo Heavy Industries Ltd., BWX Technologies Inc., Lantheus Holdings, Curium Pharma, Clarity Pharmaceuticals, Bracco Diagnostic Inc., Ion Beam Applications S.A., Nordion Inc., Eckert & Ziegler AG, NorthStar Medical Radioisotopes LLC, NTP Radioisotopes SOC Ltd, Global Medical Solutions Ltd., Isotopia Molecular Imaging Ltd., Cyclopharm Limited, Trasis NV, Orano Med LLC, ARTMS Inc., Radiomedix Inc., Coqu RadioPharmaceuticals Corp., IsoTherapeutics Group LLC
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Diagnostic Radioisotopes market Characteristics

3. Diagnostic Radioisotopes market Trends And Strategies

4. Diagnostic Radioisotopes market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Diagnostic Radioisotopes Growth Analysis And Strategic Analysis Framework

5.1. Global Diagnostic Radioisotopes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Diagnostic Radioisotopes market Growth Rate Analysis

5.4. Global Diagnostic Radioisotopes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Diagnostic Radioisotopes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Diagnostic Radioisotopes Total Addressable Market (TAM)

6. Diagnostic Radioisotopes market Segmentation

6.1. Global Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Technetium-99m

Thallium-201

Gallium-67

Iodine-123

FluoroDeoxyGlucose (FDG)

Rubidium-82

Other Radioisotopes

6.2. Global Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Single Photon Emission Computed Tomography (SPECT)

Positron Emission Tomography (PET)

Beta Emitters

6.3. Global Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Cardiology

Other Applications

6.4. Global Diagnostic Radioisotopes market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Diagnostic Centers

Academic And Research Institutes

Other End Users

6.5. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Technetium-99m, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diagnostic Imaging

Cardiac Imaging

Oncology Imaging

Bone Scans

Renal Scans

6.6. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Thallium-201, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cardiac Imaging

Myocardial Perfusion Imaging

Stress Tests

6.7. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Gallium-67, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology Imaging (Lymphoma, Tumors)

Inflammatory Disease Imaging

Infection Imaging

6.8. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Iodine-123, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Thyroid Imaging

Neurological Imaging (Parkinson's Disease)

Cardiac Imaging

6.9. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of FluoroDeoxyGlucose (FDG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Positron Emission Tomography (PET) Imaging

Cancer Diagnosis And Staging

Neurological Imaging

Cardiac Imaging

6.10. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Rubidium-82, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cardiac PET Imaging

Myocardial Perfusion Imaging

Coronary Artery Disease Diagnosis

6.11. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Other Radioisotopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Strontium-89 (Bone Pain Palliation)

Iodine-131 (Thyroid Cancer Treatment)

Samarium-153 (Bone Pain Palliation)

Yttrium-90 (Cancer Treatment)

7. Diagnostic Radioisotopes market Regional And Country Analysis

7.1. Global Diagnostic Radioisotopes market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Diagnostic Radioisotopes market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diagnostic Radioisotopes market

8.1. Asia-Pacific Diagnostic Radioisotopes market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diagnostic Radioisotopes market

9.1. China Diagnostic Radioisotopes market Overview

9.2. China Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diagnostic Radioisotopes market

10.1. India Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diagnostic Radioisotopes market

11.1. Japan Diagnostic Radioisotopes market Overview

11.2. Japan Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diagnostic Radioisotopes market

12.1. Australia Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diagnostic Radioisotopes market

13.1. Indonesia Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diagnostic Radioisotopes market

14.1. South Korea Diagnostic Radioisotopes market Overview

14.2. South Korea Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diagnostic Radioisotopes market

15.1. Western Europe Diagnostic Radioisotopes market Overview

15.2. Western Europe Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diagnostic Radioisotopes market

16.1. UK Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diagnostic Radioisotopes market

17.1. Germany Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diagnostic Radioisotopes market

18.1. France Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diagnostic Radioisotopes market

19.1. Italy Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diagnostic Radioisotopes market

20.1. Spain Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diagnostic Radioisotopes market

21.1. Eastern Europe Diagnostic Radioisotopes market Overview

21.2. Eastern Europe Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diagnostic Radioisotopes market

22.1. Russia Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diagnostic Radioisotopes market

23.1. North America Diagnostic Radioisotopes market Overview

23.2. North America Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diagnostic Radioisotopes market

24.1. USA Diagnostic Radioisotopes market Overview

24.2. USA Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diagnostic Radioisotopes market

25.1. Canada Diagnostic Radioisotopes market Overview

25.2. Canada Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diagnostic Radioisotopes market

26.1. South America Diagnostic Radioisotopes market Overview

26.2. South America Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diagnostic Radioisotopes market

27.1. Brazil Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diagnostic Radioisotopes market

28.1. Middle East Diagnostic Radioisotopes market Overview

28.2. Middle East Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diagnostic Radioisotopes market

29.1. Africa Diagnostic Radioisotopes market Overview

29.2. Africa Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diagnostic Radioisotopes market Competitive Landscape And Company Profiles

30.1. Diagnostic Radioisotopes market Competitive Landscape

30.2. Diagnostic Radioisotopes market Company Profiles

30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Sumitomo Heavy Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. BWX Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Lantheus Holdings Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Curium Pharma Overview, Products and Services, Strategy and Financial Analysis

31. Diagnostic Radioisotopes market Other Major And Innovative Companies

31.1. Clarity Pharmaceuticals

31.2. Bracco Diagnostic Inc.

31.3. Ion Beam Applications S.A.

31.4. Nordion Inc.

31.5. Eckert & Ziegler AG

31.6. NorthStar Medical Radioisotopes LLC

31.7. NTP Radioisotopes SOC Ltd

31.8. Global Medical Solutions Ltd.

31.9. Isotopia Molecular Imaging Ltd.

31.10. Cyclopharm Limited

31.11. Trasis NV

31.12. Orano Med LLC

31.13. ARTMS Inc.

31.14. Radiomedix Inc.

31.15. Coqu RadioPharmaceuticals Corp.

32. Global Diagnostic Radioisotopes market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diagnostic Radioisotopes market

34. Recent Developments In The Diagnostic Radioisotopes market

35. Diagnostic Radioisotopes market High Potential Countries, Segments and Strategies

35.1 Diagnostic Radioisotopes market In 2029 - Countries Offering Most New Opportunities

35.2 Diagnostic Radioisotopes market In 2029 - Segments Offering Most New Opportunities

35.3 Diagnostic Radioisotopes market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Diagnostic Radioisotopes market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Technetium-99m, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Thallium-201, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Gallium-67, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Iodine-123, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Diagnostic Radioisotopes Market, Sub-Segmentation Of FluoroDeoxyGlucose (FDG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Rubidium-82, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Other Radioisotopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Diagnostic Radioisotopes market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Diagnostic Radioisotopes market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Asia-Pacific, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: China, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: India, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Japan, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Australia, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Indonesia, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: South Korea, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Western Europe, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: UK, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Germany, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: France, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Italy, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Spain, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Eastern Europe, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Russia, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: North America, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: USA, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Canada, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: South America, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Brazil, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Middle East, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Africa, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: Cardinal Health Inc. Financial Performance
  • Table 83: Sumitomo Heavy Industries Ltd. Financial Performance
  • Table 84: BWX Technologies Inc. Financial Performance
  • Table 85: Lantheus Holdings Financial Performance
  • Table 86: Curium Pharma Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Diagnostic Radioisotopes market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Technetium-99m, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Thallium-201, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Gallium-67, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Iodine-123, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Diagnostic Radioisotopes Market, Sub-Segmentation Of FluoroDeoxyGlucose (FDG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Rubidium-82, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Other Radioisotopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Diagnostic Radioisotopes market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Diagnostic Radioisotopes market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Asia-Pacific, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: China, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: India, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Japan, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Australia, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Indonesia, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: South Korea, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Western Europe, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: UK, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Germany, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: France, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Italy, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Spain, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Eastern Europe, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Russia, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: North America, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: USA, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Canada, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: South America, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Brazil, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Middle East, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Africa, Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: Cardinal Health Inc. Financial Performance
  • Figure 83: Sumitomo Heavy Industries Ltd. Financial Performance
  • Figure 84: BWX Technologies Inc. Financial Performance
  • Figure 85: Lantheus Holdings Financial Performance
  • Figure 86: Curium Pharma Financial Performance

Frequently Asked Questions

Diagnostic radioisotopes refer to radioactive isotopes used in the field of nuclear medicine to diagnose and monitor various medical conditions. They utilize their radioactive decay properties to emit radiation, which is detected by specialized imaging equipment, allowing healthcare professionals to obtain detailed images of internal body structures and assess their function. For further insights on this market, request a sample here

The market major growth driver - Rising Burden Of Cancer Is Driving The Growth Of The Diagnostic Radioisotopes. For further insights on this market, request a sample here

The diagnostic radioisotopes market size has grown strongly in recent years. It will grow from $5.54 billion in 2024 to $6.08 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to the discovery of radioactivity, the introduction of technetium-99m, clinical applications and research, cold war era and nuclear research, and emergence of positron emission tomography. The diagnostic radioisotopes market size is expected to see strong growth in the next few years. It will grow to " $8.62 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to emerging radioisotope production methods, expanded clinical applications, patient-centered care and safety, point-of-care imaging and environmental sustainability and green chemistry. Major trends in the forecast period include hybrid imaging techniques, theranostics, molecular imaging techniques, the use of cyclotrons or generators, and safety and radiation protection. For further insights on this market, request a sample here

The diagnostic radioisotopesmarket covered in this report is segmented –
1) By Radioisotope: Technetium-99m; Thallium-201; Gallium-67; Iodine-123; FluoroDeoxyGlucose (FDG); Rubidium-82; Other Radioisotopes
2) By Imaging Modality: Single Photon Emission Computed Tomography (SPECT); Positron Emission Tomography (PET); Beta Emitters
3) By Application: Oncology; Cardiology; Other Applications
4) By End User: Hospitals; Specialty Clinics; Diagnostic Centers; Academic And Research Institutes; Other End Users Subsegments:
1) By Technetium-99m: Diagnostic Imaging; Cardiac Imaging; Oncology Imaging; Bone Scans; Renal Scans
2) By Thallium-201: Cardiac Imaging; Myocardial Perfusion Imaging; Stress Tests
3) By Gallium-67: Oncology Imaging (Lymphoma, Tumors); Inflammatory Disease Imaging; Infection Imaging
4) By Iodine-123: Thyroid Imaging; Neurological Imaging (Parkinson's Disease); Cardiac Imaging
5) By FluoroDeoxyGlucose (FDG): Positron Emission Tomography (PET) Imaging; Cancer Diagnosis And Staging; Neurological Imaging; Cardiac Imaging
6) By Rubidium-82: Cardiac PET Imaging; Myocardial Perfusion Imaging; Coronary Artery Disease Diagnosis
7) By Other Radioisotopes: Strontium-89 (Bone Pain Palliation); Iodine-131 (Thyroid Cancer Treatment); Samarium-153 (Bone Pain Palliation); Yttrium-90 (Cancer Treatment) For further insights on this market,
request a sample here

North America was the largest region in the diagnostic radioisotopes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diagnostic radioisotopes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the diagnostic radioisotopes market are Cardinal Health Inc., Sumitomo Heavy Industries Ltd., BWX Technologies Inc., Lantheus Holdings, Curium Pharma, Clarity Pharmaceuticals, Bracco Diagnostic Inc., Ion Beam Applications S.A., Nordion Inc., Eckert & Ziegler AG, NorthStar Medical Radioisotopes LLC, NTP Radioisotopes SOC Ltd, Global Medical Solutions Ltd., Isotopia Molecular Imaging Ltd., Cyclopharm Limited, Trasis NV, Orano Med LLC, ARTMS Inc., Radiomedix Inc., Coqu RadioPharmaceuticals Corp., IsoTherapeutics Group LLC. For further insights on this market, request a sample here.

Major trends in this market include Technological Innovation To Drive The Nuclear Medicine Radioisotopes. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon